BDBM72332 MLS000393204::N-[(1-methyl-4-piperidinylidene)amino]-4-(4-morpholinylsulfonyl)-2-nitroaniline::N-[(1-methylpiperidin-4-ylidene)amino]-4-morpholin-4-ylsulfonyl-2-nitro-aniline::N-[(1-methylpiperidin-4-ylidene)amino]-4-morpholin-4-ylsulfonyl-2-nitroaniline::SMR000248007::[(1-methyl-4-piperidylidene)amino]-(4-morpholinosulfonyl-2-nitro-phenyl)amine::cid_4136475

SMILES CN1CC[C-](CC1)\N=[NH+]\c1ccc(cc1[N+]([O-])=O)S(=O)(=O)N1CCOCC1

InChI Key InChIKey=ASRWSKUJZIPWDR-UHFFFAOYSA-O

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72332   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72332BDBM72332(Step A: 3-Chloro-2,8,9-trifluoro-10,11,12,13-tetra...)
Affinity DataIC50: 10nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent